Related Experiment Video
Updated: Sep 20, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Access to allergy care: implications for quality healthcare and public safety
William E Berger1, Lanny Rosenwasser, J Spencer Atwater
1Southern California Research, Mission Viejo, CA, USA.
Abstract:
Some managed care companies are considering reducing or eliminating coverage for several second-generation antihistamines prescribed to treat patients with allergic rhinitis, chronic idiopathic hives, and other allergy-related conditions. Treatment options for all patients with allergic and immunologic diseases should reflect accepted standards of medical care. Prescription policies limiting coverage and/or use of second-generation antihistamines are medically inappropriate, below current national standards of practice in the field of allergic and immunologic diseases, and may increase health expenditures in the long-term. Any action to reduce or limit coverage will not only diminish the quality of medical care for allergy patients but have significant health and safety implications for the general public.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Standards of Care I
Asthma-III: Symptoms and Complications
Classification of Asthma
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Asthma-I: Introduction

